Drug intelligence / Profile preview

Jiedu Yuji Ointment

Development stage: Preclinical
Lead developer: Jiangsu Province Hospital on Integration of Chinese and Western Medicine
Administration: Topical

Overview

Jiedu Yuji Ointment is a Traditional Chinese Medicine (TCM) topical formulation developed by the Jiangsu Province Hospital on Integration of Chinese and Western Medicine. It is specifically indicated for the management of hand-foot skin reactions (HFSR) induced by targeted anti-cancer therapies, such as tyrosine kinase inhibitors (e.g., sorafenib, sunitinib). The ointment is designed to reduce inflammation, promote skin barrier repair, and alleviate symptoms such as erythema, edema, pain, and hyperkeratosis associated with HFSR. It is currently undergoing clinical evaluation in multicenter, randomized, controlled trials to validate its therapeutic efficacy and safety in oncology patients.

Other names: Jiedu Yuji ointment

Beyond the preview

Go deeper on Jiedu Yuji Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiedu Yuji Ointment.

Explore the full profile